DBL Potassium Dihydrogen Phosphate Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Presentation/Packing

Concise Prescribing Info

Contents

K dihydrogen phosphate

Indications/Uses

Severe hypophosphataemia (serum levels <0.3 mmol/L) & other degrees of hypophosphataemia when oral therapy is not possible.

Click to view DBL Potassium Dihydrogen Phosphate detailed prescribing information

Dosage/Direction for Use

Adult Up to 10 mmol phosphate over 12 hr, may be repeated at 12-hr intervals until serum phosphate exceeds 0.3 mmol/L. Childn 0.15-0.33 mmol/kg over 6 hr, may be repeated at 6-hr intervals until serum phosphate exceeds 0.6 mmol/L. Rate of infusion: Not to exceed 0.2 mmol/kg/hr.

Click to view DBL Potassium Dihydrogen Phosphate detailed prescribing information

Overdosage

View DBL Potassium Dihydrogen Phosphate overdosage for action to be taken in the event of an overdose.

Contraindications

Hyperphosphataemia, hypocalcaemia, hyperkalaemia, Addison's disease, urolithiasis. Severe renal impairment.

Click to view DBL Potassium Dihydrogen Phosphate detailed prescribing information

Special Precautions

Hypoparathyroidism, rhabdomyolysis, osteomalacia, acute pancreatitis & dehydration, rickets; extensive tissue damage eg, severe burns; myotonia congenita, heart disease particularly in digitalised patients. Bone binding sites saturation. Monitor serum Na, K, phosphate, Ca conc & renal function every 12-24 hr during therapy. Chronic renal disease, severe renal insufficiency. Not recommended during pregnancy & lactation.

Click to view DBL Potassium Dihydrogen Phosphate detailed prescribing information

Use In Pregnancy & Lactation

Click to view DBL Potassium Dihydrogen Phosphate detailed prescribing information

Adverse Reactions

Hypotension, fluid retention, hyperkalaemia, hypernatraemia, hyperphosphataemia, hypocalcaemia or hypomagnesaemia, extraskeletal calcification eg, nephrocalcinosis in childn.

Click to view DBL Potassium Dihydrogen Phosphate detailed prescribing information

Drug Interactions

Hyperkalaemia w/ ACE inhibitors, digitalis glycosides, K-sparing diuretics, NSAIDs, other K-containing medicines. Increased risk of Ca deposition in soft tissues w/ Ca-containing medicines. Hyperphosphataemia w/ other phosphate-containing medicines. Increased salicylates serum conc. Incompatibility w/ Ca- or Mg-containing soln.

Click to view DBL Potassium Dihydrogen Phosphate detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view DBL Potassium Dihydrogen Phosphate detailed prescribing information

Storage

View DBL Potassium Dihydrogen Phosphate storage conditions for details to ensure optimal shelf-life.

Description

View DBL Potassium Dihydrogen Phosphate description for details of the chemical structure and excipients (inactive components).

Action

View DBL Potassium Dihydrogen Phosphate mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Electrolytes

ATC Classification

B05XA06 - potassium phosphate, incl. combinations with other potassium salts ; Belongs to the class of electrolyte solutions used in I.V. solutions.

Presentation/Packing

Form

DBL Potassium Dihydrogen Phosphate inj conc 136.1 mg/mL

Packing/Price

10 mL x 10 × 1's

DBL Potassium Dihydrogen Phosphate

potassium phosphate

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma